Japanese disproportionality analysis of finasteride ADRs, meanwhile, shows completed suicides 270% higher than expected Jan. 28, 2024 Dear Friends: Canada is taking no chances vis-á-vis finasteride wreaking havoc on its citizens’ psyches. Pre-prescription edict Last week, drug-regulatory authority (DRA) Health Canada (HC), via its monthly Health Product InfoWatch bulletin, informed its nation’s healthcare professionals that: […]
Tag Archives: Propecia product label
Internet Access to Prescription-Free Finasteride ‘Is a Serious Risk,’ Warns PFS Investigator Roberto Melcangi
‘My colleagues are seeing many cases’ of this condition, the UniMi endocrinology professor notes in his first-ever long-form TV interview Jan. 7, 2024 Dear Friends: After a decade of being reduced to mere soundbites on TV news reports, Roberto Cosimo Melcangi is finally getting some quality time in the spotlight. Last month, Italy’s Byoblu TV—having […]
ED that Occurs During Finasteride Treatment Differs from ED that Persists Post-Treatment, Says New UniMi Research
PFS Investigator Roberto Melcangi suspects the post-treatment variety springs from neuroendocrine disorder, rather than genital pathology Aug. 28, 2023 Dear Friends: Finasteride use can, and does, lead to erectile dysfunction that can, and does, last indefinitely in a subset of patients. By this point in the epidemiology of PFS, few self-respecting doctors would argue with […]
51% of Dermatologists Believe Finasteride ‘May Cause’ Sexual Side Effects—but Only 18% Believe those ADRs May Persist, Says New Harvard Medical School Research
Pioneering PFS investigator Michael Irwig also finds that just 13% of respondents believe finasteride could cause depression, while 54% believe the drug is ‘unlikely’ or ‘very unlikely’ to do so Aug. 16, 2023 Dear Friends: Despite the fact that the finasteride product label has included depression and persistent loss of libido as possible side effects […]
Neuropsychiatric Side Effects for Finasteride Housed on FDA Database Show Disproportionate Safety Signals Compared to Control Meds—and a ‘Striking Increase in Suicides’—Says New Research
Following new safety review, Health Canada working with finasteride manufacturers to strengthen suicidality warning March 27, 2023 Dear Friends: Although the US Food and Drug Administration rarely mentions PFS, its database of side effects speaks volumes about the condition’s epidemiology. Out of control According to new research based in part on the agency’s Adverse Event […]
Study Used to Push Non-FDA-Approved Topical Finasteride Knocked by Top German Rx Journal
‘It is still unclear to what extent the lower systemic drug exposure translates into a lower risk of side effects,’ says Deutsche Apotheker Zeitung. ‘The limited number of patients makes it difficult to draw reliable conclusions.’ March 20, 2023 Dear Friends: Germany’s oldest and most widely read pharmaceutical journal has taken a deep dive into […]
UK Drug Regulatory Authority MHRA Investigating Finasteride Safety
Probe launched after tête-à-tête with French counterpart ANSM, whose ‘red box’ warning will be slapped on all finasteride 1 mg packaging next month March 5, 2023 Dear Friends: The British are coming—hopefully with a PFS-awareness program on par with that of the French. Dr. White does right According to a February 16 memo from Amelia […]
Topical Finasteride Could Precipitate PFS, Top German Rx Journal Warns
Stricken US college student corroborates red flag raised to 29,000 pharmacists Feb. 27, 2023 Dear Friends: Spraying finasteride on your scalp instead of ingesting it is no guarantee you won’t develop post-finasteride syndrome (PFS). So cautions Germany’s oldest and most widely read pharmaceutical journal. So, too, an American college senior who says his academic, social […]
France Orders ‘Red-Box’ Warning—and QR Code Linking to PFS-Awareness Dossier—Slapped on all Finasteride 1 mg Products by April
Dec. 4, 2022 Dear Friends: French PFS awareness is going high-tech. ANSM, the Gallic nation’s drug-regulatory authority (DRA), last week unveiled plans to add a so-called “red-box” warning—that includes a QR code—on all finasteride 1 mg products in 2023. Intended to “reinforce information on adverse effects” of Propecia and generics, the warning reads: This medication […]